Experts discuss sequencing strategies in renal cell carcinoma (RCC), focusing on optimizing treatment selection after ...
Experts discuss first-line treatment strategies for renal cell carcinoma (RCC) in 2025, navigating the evolving therapeutic landscape.
Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from KN026-docetaxel combination therapy. Lerociclib plus fulvestrant demonstrated a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback